Fmoc-Gly-OH: The Foundation of Advanced Peptide Synthesis
Discover the purity and versatility of Fmoc-Gly-OH, your essential partner in peptide and proteomics research.
Get a Quote & SampleProduct Core Value

Fmoc-Gly-OH
Fmoc-Gly-OH is a critical Fmoc-protected glycine derivative, recognized as the simplest amino acid building block. Its non-chiral nature and high purity make it indispensable for advanced peptide synthesis techniques, including Solid Phase Peptide Synthesis (SPPS). It serves as a fundamental component in creating complex peptide sequences for various research applications.
- Benefit from high purity Fmoc-Gly-OH, ensuring reliable outcomes in your peptide synthesis projects.
- Leverage the versatility of this glycine derivative for research in proteomics and biochemical studies.
- Utilize this essential building block for efficient solid phase peptide synthesis (SPPS).
- Ensure precision in your work with a compound that boasts very low levels of dipeptide and free-amino acid impurities.
Key Advantages
Exceptional Purity
Source high-purity Fmoc-Gly-OH, a critical factor for achieving accurate and reproducible results in complex synthesis protocols.
Versatile Application
This fundamental glycine derivative for research is applicable across numerous fields, from drug discovery to material science.
Cost-Effective Solutions
Explore competitive pricing and various pack sizes for buy Fmoc-Gly-OH online, catering to both small-scale research and larger production needs.
Key Applications
Peptide Synthesis
Essential for the controlled assembly of peptide chains, where its Fmoc protection strategy is widely employed.
Proteomics Research
Used in the study of proteins and their functions, contributing to a deeper understanding of biological processes.
Biochemical Studies
Serves as a fundamental reagent in various biochemical investigations, aiding in the discovery of new compounds and pathways.
Drug Discovery
A crucial intermediate in the synthesis of novel therapeutic agents, facilitating the development of new medicines.